Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for hyperactivity and attention difficulties in youngsters and individuals. In Canada, its access is overseen by Health Canada. https://apo-lisdexamfetamine-pri034735.weblognation.com/61715812/this-medication-in-canada-a-complete-guide